locus of immune response control is located between the H-2S and D regions. In addition, a monoclonal antibody directed against this right-hand region of control has been produced (48-21.7 ) that blocks the response to TNP-Ficoll at the level of the antigen-presenting cell. The monoclonal antibody 48-21.7 is specific for the high responder b allele at the right-hand locus and does not inhibit responses to other protein antigens tested. The immune response to TNP-Ficoll is not inhibited by monoclonal antibodies that react with H-2D b or Qa-2 specificities, suggesting that the TNP-Ficoll response is controlled by a unique locus located between H-2S and D. Finally, 48-21.7 recognizes and precipitates an unique product of ~40,000 mol wt that is distinct from the H-2D b region product recognized by the monoclonai antibody B22/249.
Materials and Methods
Mice. All mice were bred in our colony at the University of Michigan and used when 2-6 mo old. Original breeders were obtained from The Jackson Laboratory, Bar Harbor, ME and from Dr. Donald Shreffler, Washington University, St. Louis, MO.
Antigens. TNP-aminoethyl carbamethyl (AECM)-Ficoll (conjugation ratio, TNP34-AECM-FicolI), was obtained from Biosearch Laboratories, San Rafael, CA. TNP-bovine gamma globulin (TNP-BGG) was purchased from Calbiochem-Behring Corp., San Diego, CA, and contained 61 TNP groups per molecule of BGG.
Antisera. Restricted anti-Ia alloantisera were prepared as previously described (13) (14) (15) . Batches of serum from several bleedings were tested in a dye exclusion microcytotoxicity assay for appropriate anti-Ia reactivity and antibody titer (15) . The hybridoma cell lines MKD6 (anti-I-A a) and MKS4 (anti-I-A s) were gifts from Dr. Phillippa Marrack, National Jewish Hospital, Denver, CO. The cell line producing monoclonal antibodies directed against specificity Ia. 17 (10-2.16) was obtained from the Salk Cell Distribution Center, La Jolla, CA. Monoclonal antibody Y-7KB (anti-Qa-2 a) was a gift from Dr. Donal Murphy, Yale University, New Haven, CT.
Cell Culture Conditions. Single-cell suspensions of individual spleens were prepared and seeded at 4 x 106 lymphocytes per well (four wells per condition) in Mishell-Dutton culture medium (16) with 10% fetal calf serum (FCS) (Reheis Co. Inc., Phoenix, AZ). Cultures were established in 24-well plates (Costar, Data Packaging Corp., Cambridge, MA). Antigen was added at a final concentration of 0.1 #g/ml TNP-Ficoll or 5 #g/ml TNP-BGG in a final volume of 1 ml/well. Plates were incubated for 4 d at 37°C in 7% CO> For experiments requiring purified cell preparations, separation of the cells was accomplished using previously published procedures (17, 18) . Briefly, for peritoneal macrophage isolation, mice were injected intraperitoneally with 45 /~g of concanavalin A (Con A) (Pharmacia Fine Chemicals, Piscataway, NJ) in 1.5 ml phosphate-buffered saline (PBS). 3 d later, peritoneal exudate cells were harvested by flushing the peritoneum with cold tissue culture medium containing 0.1 M Hepes and 10% FCS. Cells were pelleted, resuspended, and the number of viable cells determined. These cells have been demonstrated to be ~70% Ia + macrophages. Purified macrophages were seeded in 24-well Costar plates at the desired number of Ia ÷ macrophages; usually 5% of the number of macrophage-depleted cells were added per well. The cells were allowed to adhere for 2 h, washed to remove nonadherent cells, treated with mitomycin C (Sigma Chemical Co., St. Louis, MO), and extensively washed. In antibody pretreatment experiments, 0.5 ml of appropriately diluted antibody was added per well; macrophages were then incubated for 45 min and washed four times with fresh medium.
Macrophage-depleted spleen cells were prepared by repeated incubation of cells with carbonyl iron powder (Atomergic Chemetals Corp., Plainview, NY) and removal of phagocytic cells with a strong magnet. Cells incorporating latex particles and having morphologic characteristics of macrophages comprised <1% of this remaining cell popu-lation. Total cell loss with this procedure was 40-50%, but no difference in the T cell/B cell ratio could be discerned.
Controls for each experiment included: macrophage-depleted spleen cells plus antigen; untreated macrophages plus antigen; and macrophages pretreated with antibody plus antigen. These controls produced no plaque-forming cells (PFC) in any experiment.
Local Hemolysis in Gel. TNP-specific, IgM antibody-producing cells were assayed on day 4 of the culture period by a modified Jerne technique (19, 20) . Sheep erythrocytes were lightly conjugated with TNP and used to determine the number of direct PFC (21) . Greater than 90% of PFC were inhibited by 10 -2 M TNP-lysine. Results were corrected for background PFC using nohaptenated sheep erythrocytes.
Production of Antibody-secreting Hybrid Cell Lines. 6-8-wk-old female B10.A(3R) mice were initially injected with 2 x 107 lymphoid cells from C57BL/6 mice both intraperitoneally and subcutaneously, followed 1 wk later by an intravenous injection. After six injections, the mice were bled and the serum tested for activity. 3 d after the last injection, when the serum had the desired activity, the mice were boosted and the immune spleen cells were fused with P3X63-Ag8.653 myleoma cells (22) (23) (24) . Fine Specificity Testing. Clones that were positive for antibody production were screened for their ability to block the in vitro primary antibody response to TNP-Ficoll in the high responder D2.GD strain. Positive clones were subcioned twice by limiting dilution and tested for maximum inhibitory capacity. Supernatants from expanding cultures were collected, processed, and stored at -20°C. In addition, high titer antibody was produced by inducing ascites tumors in [BALB/c X B10.A(3R)]F1 mice primed with pristane (2,6,10,14-tetramethylpentadecane, 96%) (Aldrich Chemical Co., Milwaukee, WI). Monoclonal antibody 48.21, an IgM class antibody, was purified by Sephacryl S-300 gel filtration of the 40% ammonium sulfate fraction of ascites. Purity of the IgM preparation was determined by SDS-PAGE.
Radiolabeling and Precipitation of Antigens.
The procedures for radiolabeling mouse spleen lymphocytes and for extracting and immunoprecipitation of antigens are modifications of those described by Jones (25) . Briefly, splenic lymphocytes were incubated for 4-5 h at 25 x 10 6 cells/ml in methionine-free RPMI 1640 medium containing 5% FCS and 250 ~Ci/ml [35S]methionine/ml (1,000 mCi/mmol; New England Nuclear, Boston, MA). Membrane proteins were extracted from washed cells with 0.5% Nonidet P-40 (BioRad Laboratories, Richmond, CA) buffer. Immune complexes were removed from lysates by centrifugation at 15,000 g for 15 min and incubation for 3 h with Staphylococcus protein A-coupled Sepharose beads (Staph A beads) (Pharmacia Fine Chemicals, Piscataway, N J). Antigens were immunoprecipitated from the extracts with either supernatants from antibody-producing hybridomas or purified ascites. Lysates were incubated with the antibody overnight, followed by the addition of Staph A beads or, for IgM antibodies, Staph A beads complexed with rabbit anti-mouse IgM, A, and G (Accurate Chemical & Scientific Co., Westbury, NY). The bound proteins were eluted from the Staph A with electrophoresis buffer containing sodium dodecyl sulfate (SDS) (Bio-Rad Laboratories) and 2-mercaptoethanol (2-ME) (Aldrich Chemical Co.) for reducing gels or without 2-ME for nonreducing analysis.
SDS-PAGE Analysis. Precipitated proteins were separated in 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels according to standard procedures. Separating gels contained 12% acrylamide (Bio-Rad Laboratories) with 0.5% N,N-diallyltartardiamide (DATD) crosslinker and 0.1% SDS. Stacking gels contained 4% acrylamide; 25 ~1 vol protein samples were added to each lane and gels were electrophoresed at 25 mA/gel. They were then fixed in 30% methanol, 10% acetic acid, 10% TCA; enhanced in 1.0 M sodium salicylate, dried, and autoradiographed for 4 d at -70°C.
Results
We have previously reported (12) Because the strains mapping the right-hand locus of control were of different haplotype combinations, it was possible that the differences in response observed between the B10.S(7R) and the B10.A(2R) strains were due to differences in genetic organization of the two haplotypes (s vs. a) rather than differences introduced by recombination. To eliminate this possibility, three congenic strains (developed by Dr. Shreffler, Washington University, St. Louis, MO) with recombination occurring between the H-2S and H-2D regions were studied. Each of these strains was independently derived from a (B10 X B10.A) parental cross and identified as a recombinant by serological analysis (26) . The results of challenging these strains with TNP-Ficoll and the control antigen TNP-BGG are shown in Table I 2) have demonstrated that the response to TNP-Ficoll is significantly inhibited by pretreatment of complementing (low responder × low responder)F~ macrophages with antiserum directed toward high responder determinants of either locus, while antibodies directed toward the corresponding low responder determinants have no effect. These results indicated that antibodies directed toward specific determinants could be used in functional assays to identify those cell surface antigens directly involved in controlling the response to TNP-Ficoll. To confirm the recombinant analysis of the TNP-Ficoll response and to investigate the role of the H-2D region in its control, antibody blocking studies were performed. Con A-induced peritoneal exudate cells were used as a source of macrophages in these experiments. These cells were purified and pretreated with either alloantiserum or monoclonal antibodies and mitomycin C, washed extensively, and cultured with syngeneic carbonyl iron-treated spleen cells and antigen as described in Materials and Methods.
Comparison of Antibody Responses to TNP-Ficoll in Strains with Crossovers Between the H-2S and H-2D Regions
Initial blocking experiments showed that both alloantiserum and monoclonal antibodies directed against high responder I-A specificities effectively blocked the response to TNP-Ficoll. Blocking of the right-hand region of control was demonstrated by inhibition of the response with the broadly specific B10.A(3R) anti-C57BL/6 alloantiserum, which contained antibodies directed against membrane-expressed gene products of the I-E through H-2D segment of the high responder b haplotype (Fig. 2) . The anti-D b activity of this antisera could be absorbed with EL-4 cells that bear class I but not class II molecules. Absorption of anti-D b activity was confirmed by cytotoxic tests (data not shown). As shown in Fig. 2 , the ability of this antiserum to block the TNP-Ficoll response is unaffected by removal of anti-D b activity.
To produce a specific probe to the right-hand locus of control, spleens from mice producing the B10.A(3R) anti-C57BL/6 alloantiserum (anti-Eb-D b) were fused with the P3X63Ag8.653 myeloma (22) . Antibodies produced by the resulting hybridomas were screened for their ability to block the D2.GD response to TNP-Ficoll. The results of the screening of two different subclones of monoclonal antibody 48-21 are shown in Fig. 3 . Pretreatment of macrophages with antibodies from either 48-21.7 or 48-21.4 subclones resulted in inhibition equivalent to that obtained with B10.A(3R) anti-C57BL/6 alloantiserum.
Further characterization of the specificity of monoclonal antibody 48-21.7 included assessment of its effect on responses to other antigens. Fig. 4 illustrates that 48-21.7 did not alter the primary antibody responses of high responder D2.GD animals to the T-dependent antigen TNP-BGG. Pretreatment of macrophages with 48-21.7 blocked the TNP-Ficoll response by 62%, yet with identical pretreatment it had no effect on the primary response to TNP-BGG. In addition, pretreatment of macrophages with 48-21.7 had no effect on secondary responses to either LDH-B or MOPC-173 as measured in the T cell prolif- In an effort to rule out an H-2D region contribution to the control of the response to TNP-FicoII, D2.GD macrophages were pretreated with a monoclonal antibody (B22/249) that specifically recognized the class I determinant H-2D b (27, 28). Fig. 6 illustrates that macrophage pretreatment with monoclonal antibody B22/249 had no effect on the response to TNP-FicolI. In addition, this result indicates that binding of the antibody B22/249 to the D2.GD macrophage cell surface, as demonstrated by cytotoxic tests, is not sufficient to inhibit their ability to generate a TNP-Ficoll PFC response. Discussion The experiments presented demonstrate that the primary in vitro antibody response to TNP-Ficoll is controlled by two complementing loci. Recombinant analysis mapped one locus to the I-A subregion, and the second locus between the S and D regions. Other investigators (B2) have also found evidence for immune response control loci outside of the I region and close to the D end of the H-2 complex. Berzofsky et al. (2) showed that the antibody response to equine myoglobin was controlled by two complementing genes, one in I-A and a second in tt-2D. This conclusion was reached by recombinant analysis and confirmed by testing strain tt-2 ~mt, which has a mutation in the H-2D region (B3). In addition, a genetic region between S and D, designated H-2U by O'Neill and Parish (B4), was identified by alloantisera produced in strains that differed at the D region. This allosera retained activity against several target strains after absorption to remove D-specific antibodies. The H-2U region appears to control antigens similar in their cellular distribution and molecular weight to Ia antigens. Krco et al. (35) demonstrated that the control of the T cell proliferative response to hemoglobin mapped to two separate Ir genes, one of which mapped to the D end of the 1-1-2 complex. Recombinant strains challenged with intact hemoglobin or the alpha subunit demonstrated I-A region control (BS), whereas challenge with the beta chain subunit exhibited control mapping to the H-2D region.
In addition to the evidence placing lr genes between the S and D regions, other evidence has mapped genes controlling the phenotypic expression of certain enzymes to the region near the H-2D. For example, Neu-1, a locus controlling the activity of the enzyme neuraminidase, which alters the sialation of at least five different enzymes, has been closely linked to the D region (B6, 37). Variants of these enzymes were originally thought to be controlled by .separate loci mapping to H-2, but now variants appear to be the result of different alleles of the Neu-1 locus (38) . It is important to note, however, that the patterns of allelic variation of Neu-1 do not follow the patterns of high and low response established for the response to TNP-Ficoll. For example, Cfi7BL/10 and BALB/ c strains both have the Neu-1 b allele but C57BL/10 carries the TNP-Ficoll high responder b haplotype, and BALB/c, the low responder d haplotype. It is unlikely, therefore, that the Neu-1 locus is involved in the regulation of the Ficoll response.
The existence of multiple genes mapping to the right end of the MHC, and the presence of genes that control or modify the expression of other molecules on the cell surface, raised the possibility that the product of the right-hand locus which controls the response to TNP-Ficoll did not function in a manner similar to an Ia antigen. In fact, the molecular weight of the product recognized by monoclonal antibody 48-21.7 indicated that this could be the case. The 40 K tool wt protein, immunoprecipitated with 48-21.7, was more similar to that of a class I or class I-related (Qa, Tla) gene product than a typical class II gene product.
Molecular data has shown that the d haplotype contains 36 distinct class I genes (39) . 31 of the 36 class I genes have been mapped to the Qa and Tla regions of the MHC, while the other five map to H-2K and D regions (40) . Studies of the b haplotype have indicated 23 of 26 class I genes in this haplotype to map to the Qa-2,3 and TL regions (41). To date, the function and expression of the products of most of these genes is unknown.
The presence of genes in the region between H-2S and Tla that control the quantitative expression of the class I-related antigens Qa-1 and, perhaps, Qa-2, has raised the possibility that Qa-1 or Qa-2 were in someway responsible for the different levels of response to TNP-Ficoll (29, 30) . Quantitative as well as qualitative differences in expression of Qa-1 specifities in certain mouse strains have been demonstrated by variations in cytotoxicity and absorption of antiserum activity. For example, H-2D k strains express less of the Qa-1 antigen than other strains (29) . Similarly, immunochemical and serological studies demonstrated that different strains expressed varying amounts of the Qa-2 antigen, and recombinant analysis suggested that these quantitative differences were due to modifying genes located to the right of the S region, distinct from the Qa structural genes (30, 42, 43) . In some instances, quantitative variation in expression of class I molecules has been shown to influence function. For example, the amount of H-2D product on the cell surface correlates with resistance to virus infection (44) and with immunity against virus-infected cells (45) . However, it is unlikely that Qa or H-2D molecules are involved in regulation of the immune response to TNP-FicolI.
The strongest evidence against involvement of Qa-2 molecules in the regulation of the TNP-Ficoll response was the failure of the anti-Qa-2 monoclonal antibody to block the response. Of course, the failure of a single anti-Qa-2 antibody to inhibit the response to TNP-Ficoll does not rule out the possibility that other Qa molecules play a role. However, if 48.21.7 recognizes either a Qa-2 ~ determinant or the product of the gene, located between H-2D and Tla, that regulates the quantitative expression of Qa-2, then the anti-Qa-2 a antibody Y-7KB would be expected to block the immune response.
Experiments in which responding cells were pretreated with antibody and complement demonstrated that the specificity recognized by 48-21.7 Our results are consistent with the hypothesis that monoclonal antibody 48-21.7 recognizes the product of a novel class I-related gene that is located between the S and D loci. Immunoprecipitation analysis strongly suggests that the product recognized by 48-21.7 was distinct from either the class I H-2D b molecule or an Ia molecule. We do not know for certain whether the 48.21.7 molecule is associated with/32-microglobulin; reduced SDS-polyacrylamide gels occasionally show a very faint band at 12 K mol wt. Since we have seen variable amounts of /32-microglobulin precipitated with our O b reagents, it is possible that an association between /3,, and the 48.21.7 molecule occurs but is of lower affinity than most class I molecules. The observation that there may be no association of the product recognized by 48-21.7 and/32-microglobulin may have functional significance. In an earlier study (48) , cells transfected with clones of class I genes were assayed for an increase in ~32-microglobulin as an indicator of foreign class I antigen expression. Transfected genes that did not result in increased levels of /~2-microglobulin were assumed not to encode class I gene products. However, not all of the class I genes identified by Southern blot analysis of the murine genome were positive in this assay (48) . It is possible that one of the genes which does not associate with/32-microglobulin codes for the unique product precipitated by 48.21.
One possibility which cannot be excluded is that the recombinant analysis located a regulatory gene between S and D which controls the expression of a cell surface antigen encoded elsewhere. In such a model, the surface antigen would be involved in the regulation of the response to TNP-Ficoll and be recognized by the monoctonal antibody 48-21.7. It should be noted, however, that a regulatory gene of this nature would have to exert its control on allelic structural genes in a haplotype-specific manner. While this is possible, no such mechanism has been reported (49) .
The relationship of the two loci required for the response to TNP-Ficoll remains unclear. Blocking experiments indicated that cell surface expression of high responder alleles of both loci are mandatory for optimum response. Immunoprecipitation analysis suggested that there was no physical association between the I-A gene product and the product of the right-hand locus because antibodies specific for each of these loci precipitated distinct products (data not shown). The functional role of each of these molecules is unclear. It is possible that the 1-A molecule acts as a traditional Ia antigen recognition structure together with some other type of receptor, membrane-bound enzyme, or another surface determinant encoded between the H-2S and D regions. There are several instances of interactions between genes of the MHC. In addition to the complementation of genes in the I-A and I-E regions for an Ia molecule (50) , there are examples of interactions between the H-2D and Qa and Tla regions leading to altered expression of one of the molecules (29, 30, 51) . Since an immune response function is associated with the 48.21.7 molecule, the TNP-Ficoll system may prove to be a useful model for studying these interactions. It will be particularly interesting to determine whether the 48.21 locus corresponds to any of the cloned genes clustering in this region for which no function or product has yet been shown. Further characterization of the 48.21.7 product and its locus is in progress.
Summary
The primary in vitro antibody response to the type 2 antigen, trinitrophenyl (TNP)-Ficoll, is controlled by two complementing loci in the H-2 region of the mouse major histocompatibility complex (MHC). High responder alleles at both loci are necessary for a high responder phenotype. Previous studies mapped one locus of control to the 1-A subregion. In this report we demonstrate by recombinant analysis that the second locus of control is located between the H-2S and D regions. A comparison of responses in the B10.BAR6, B10.BAR10, and B10.BAR11 strains defined a locus controlling the response to TNP-Ficoll in a single haplotype, bounded on the left by the crossover event in the B 10.BAR 10 and on the right by the crossover event in the B10.BAR6 strain. A monoclonal antibody directed against this right-hand region of control has been produced (48.21.7) that blocks the response to TNP-Ficoll at the level of the antigenpresenting cell. The monoclonal antibody 48-21.7 is specific for the high responder b allele at the right-hand locus and did not inhibit responses to other protein antigens tested. The imnmne response to TNP-Ficoll was not inhibited by monoclonal antibodies that react with H-2D b or Qa-2 specificities, suggesting that the TNP-Ficoll response is controlled by a unique locus located between H-2S and D. Finally, 48-21.7 recognizes and precipitates a unique product of ~40,000 mol wt that is distinct from the H-2D region product recognized by the monoclonal antibody B22/249.
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